Burdi, Rosa <br/><br/>
First evaluation of the potential effectiveness in muscular dystrophy of a novel chimeric compound, BN 82270, acting as calpain-inhibitor and anti-oxidant.  [electronic resource] 

 -  Neuromuscular disorders : NMD  Apr 2006 
 - 237-48 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0960-8966 
<br/><br/><label>Standard No.: </label>10.1016/j.nmd.2006.01.013  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antioxidants--pharmacology<br/>Biomechanical Phenomena<br/>Body Weight<br/>Calpain--physiology<br/>Chloride Channels--drug effects<br/>Creatine Kinase--blood<br/>Diaphragm--drug effects<br/>Glycoproteins--pharmacology<br/>Hindlimb<br/>Male<br/>Mice<br/>Mice, Inbred C57BL<br/>Mice, Inbred mdx<br/>Muscle Fibers, Skeletal--drug effects<br/>Muscle, Skeletal--drug effects<br/>Muscular Dystrophy, Animal--drug therapy<br/>Phenothiazines--therapeutic use<br/>Physical Conditioning, Animal<br/>Prodrugs--pharmacology<br/>Rats<br/>Rats, Sprague-Dawley<br/>Transforming Growth Factor beta--blood<br/>Transforming Growth Factor beta1